Listed

Enveric Biosciences, Inc.: Form 10-Q/A for the period ended Mar 31, 2014

Filed with the SEC on May 8, 2014 and accepted by EDGAR at May 8, 2014, 15:13 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Operating income3 months2014-01-01 to 2014-03-31−$7.6kus-gaap:OperatingIncomeLoss
Income tax3 months2014-01-01 to 2014-03-31−$283us-gaap:IncomeTaxExpenseBenefit
Net income3 months2014-01-01 to 2014-03-31−$7.9kus-gaap:NetIncomeLoss
Diluted EPS3 months2014-01-01 to 2014-03-31$0.00us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow3 months2014-01-01 to 2014-03-31−$27.8kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2014-03-31$22.5kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-03-31$26.7kus-gaap:AssetsCurrent
Total assetsAt period end2014-03-31$26.7kus-gaap:Assets
Current liabilitiesAt period end2014-03-31$4.8kus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2014-03-31$21.9kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001248915-14-000091. Last ingested by Listed: Nov 14, 2026, 20:02 ET. Listed shows no prices and gives no investment advice.